471 related articles for article (PubMed ID: 21499247)
21. Low-copy piggyBac transposon mutagenesis in mice identifies genes driving melanoma.
Ni TK; Landrette SF; Bjornson RD; Bosenberg MW; Xu T
Proc Natl Acad Sci U S A; 2013 Sep; 110(38):E3640-9. PubMed ID: 24003131
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer.
Bell SM; Shaw M; Jou YS; Myers RM; Knowles MA
Genomics; 1997 Sep; 44(2):163-70. PubMed ID: 9299232
[TBL] [Abstract][Full Text] [Related]
23. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.
Robbins PF; El-Gamil M; Li YF; Kawakami Y; Loftus D; Appella E; Rosenberg SA
J Exp Med; 1996 Mar; 183(3):1185-92. PubMed ID: 8642260
[TBL] [Abstract][Full Text] [Related]
24. Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.
Hintzsche JD; Gorden NT; Amato CM; Kim J; Wuensch KE; Robinson SE; Applegate AJ; Couts KL; Medina TM; Wells KR; Wisell JA; McCarter MD; Box NF; Shellman YG; Gonzalez RC; Lewis KD; Tentler JJ; Tan AC; Robinson WA
Melanoma Res; 2017 Jun; 27(3):189-199. PubMed ID: 28296713
[TBL] [Abstract][Full Text] [Related]
25. Investigation of GRIN2A in common epilepsy phenotypes.
Lal D; Steinbrücker S; Schubert J; Sander T; Becker F; Weber Y; Lerche H; Thiele H; Krause R; Lehesjoki AE; Nürnberg P; Palotie A; Neubauer BA; Muhle H; Stephani U; Helbig I; Becker AJ; Schoch S; Hansen J; Dorn T; Hohl C; Lüscher N; ; ; von Spiczak S; Lemke JR
Epilepsy Res; 2015 Sep; 115():95-9. PubMed ID: 26220384
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide screen of promoter methylation identifies novel markers in melanoma.
Koga Y; Pelizzola M; Cheng E; Krauthammer M; Sznol M; Ariyan S; Narayan D; Molinaro AM; Halaban R; Weissman SM
Genome Res; 2009 Aug; 19(8):1462-70. PubMed ID: 19491193
[TBL] [Abstract][Full Text] [Related]
27. Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.
Cohen CJ; Gartner JJ; Horovitz-Fried M; Shamalov K; Trebska-McGowan K; Bliskovsky VV; Parkhurst MR; Ankri C; Prickett TD; Crystal JS; Li YF; El-Gamil M; Rosenberg SA; Robbins PF
J Clin Invest; 2015 Oct; 125(10):3981-91. PubMed ID: 26389673
[TBL] [Abstract][Full Text] [Related]
28. Altered expression and new mutations in DNA mismatch repair genes MLH1 and MSH2 in melanoma brain metastases.
Korabiowska M; König F; Verheggen R; Schlott T; Cordon-Cardo C; Romeike B; Brinck U
Anticancer Res; 2004; 24(2B):981-6. PubMed ID: 15161053
[TBL] [Abstract][Full Text] [Related]
29. Detection of a low frequency of activated ras genes in human melanomas using a tumorigenicity assay.
Raybaud F; Noguchi T; Marics I; Adelaide J; Planche J; Batoz M; Aubert C; de Lapeyriere O; Birnbaum D
Cancer Res; 1988 Feb; 48(4):950-3. PubMed ID: 3276402
[TBL] [Abstract][Full Text] [Related]
30. Frequent mutations in the MITF pathway in melanoma.
Cronin JC; Wunderlich J; Loftus SK; Prickett TD; Wei X; Ridd K; Vemula S; Burrell AS; Agrawal NS; Lin JC; Banister CE; Buckhaults P; Rosenberg SA; Bastian BC; Pavan WJ; Samuels Y
Pigment Cell Melanoma Res; 2009 Aug; 22(4):435-44. PubMed ID: 19422606
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee.
Hamza TH; Chen H; Hill-Burns EM; Rhodes SL; Montimurro J; Kay DM; Tenesa A; Kusel VI; Sheehan P; Eaaswarkhanth M; Yearout D; Samii A; Roberts JW; Agarwal P; Bordelon Y; Park Y; Wang L; Gao J; Vance JM; Kendler KS; Bacanu SA; Scott WK; Ritz B; Nutt J; Factor SA; Zabetian CP; Payami H
PLoS Genet; 2011 Aug; 7(8):e1002237. PubMed ID: 21876681
[TBL] [Abstract][Full Text] [Related]
32. GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers.
Li D; Yuan H; Ortiz-Gonzalez XR; Marsh ED; Tian L; McCormick EM; Kosobucki GJ; Chen W; Schulien AJ; Chiavacci R; Tankovic A; Naase C; Brueckner F; von Stülpnagel-Steinbeis C; Hu C; Kusumoto H; Hedrich UB; Elsen G; Hörtnagel K; Aizenman E; Lemke JR; Hakonarson H; Traynelis SF; Falk MJ
Am J Hum Genet; 2016 Oct; 99(4):802-816. PubMed ID: 27616483
[TBL] [Abstract][Full Text] [Related]
33. Functional Investigation of a GRIN2A Variant Associated with Rolandic Epilepsy.
Xu XX; Liu XR; Fan CY; Lai JX; Shi YW; Yang W; Su T; Xu JY; Luo JH; Liao WP
Neurosci Bull; 2018 Apr; 34(2):237-246. PubMed ID: 28936771
[TBL] [Abstract][Full Text] [Related]
34. [Melanoma: from molecular studies to the treatment breakthrough].
Imianitov EN
Arkh Patol; 2013; 75(5):63-72. PubMed ID: 24341237
[TBL] [Abstract][Full Text] [Related]
35. Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivo.
Labelle-Côté M; Dusseault J; Ismaïl S; Picard-Cloutier A; Siegel PM; Larose L
BMC Cancer; 2011 Oct; 11():443. PubMed ID: 21992144
[TBL] [Abstract][Full Text] [Related]
36. Somatic Hypermutation of the
Zhang X; Tang JZ; Vergara IA; Zhang Y; Szeto P; Yang L; Mintoff C; Colebatch A; McIntosh L; Mitchell KA; Shaw E; Rizos H; Long GV; Hayward N; McArthur GA; Papenfuss AT; Harvey KF; Shackleton M
Mol Cancer Res; 2019 Jul; 17(7):1435-1449. PubMed ID: 30833299
[TBL] [Abstract][Full Text] [Related]
37. Regulation of NR4A nuclear receptor expression by oncogenic BRAF in melanoma cells.
Smith AG; Lim W; Pearen M; Muscat GE; Sturm RA
Pigment Cell Melanoma Res; 2011 Jun; 24(3):551-63. PubMed ID: 21362156
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy.
Norton N; Li D; Rieder MJ; Siegfried JD; Rampersaud E; Züchner S; Mangos S; Gonzalez-Quintana J; Wang L; McGee S; Reiser J; Martin E; Nickerson DA; Hershberger RE
Am J Hum Genet; 2011 Mar; 88(3):273-82. PubMed ID: 21353195
[TBL] [Abstract][Full Text] [Related]
39. Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas.
Smalley KS; Lioni M; Dalla Palma M; Xiao M; Desai B; Egyhazi S; Hansson J; Wu H; King AJ; Van Belle P; Elder DE; Flaherty KT; Herlyn M; Nathanson KL
Mol Cancer Ther; 2008 Sep; 7(9):2876-83. PubMed ID: 18790768
[TBL] [Abstract][Full Text] [Related]
40. Identification of a novel mutation in a Chinese family with Nance-Horan syndrome by whole exome sequencing.
Hong N; Chen YH; Xie C; Xu BS; Huang H; Li X; Yang YQ; Huang YP; Deng JL; Qi M; Gu YS
J Zhejiang Univ Sci B; 2014 Aug; 15(8):727-34. PubMed ID: 25091991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
